Bicocca Open Archive

Logo unimib boa
STRAZZABOSCO, MARIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 25.624
AS - Asia 11.110
EU - Europa 10.237
SA - Sud America 1.628
AF - Africa 162
Continente sconosciuto - Info sul continente non disponibili 33
OC - Oceania 23
Totale 48.817
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 25.090
SG - Singapore 3.776
CN - Cina 3.094
HK - Hong Kong 2.053
RU - Federazione Russa 1.904
SE - Svezia 1.634
IT - Italia 1.370
BR - Brasile 1.323
DE - Germania 1.298
IE - Irlanda 1.242
UA - Ucraina 1.137
VN - Vietnam 1.084
GB - Regno Unito 594
CA - Canada 432
FI - Finlandia 304
KR - Corea 241
IN - India 215
FR - Francia 177
AR - Argentina 145
TR - Turchia 126
AT - Austria 115
DK - Danimarca 103
NL - Olanda 97
BD - Bangladesh 83
ZA - Sudafrica 83
JP - Giappone 76
MX - Messico 73
IQ - Iraq 69
ID - Indonesia 67
BE - Belgio 46
PL - Polonia 45
EC - Ecuador 44
ES - Italia 42
CO - Colombia 31
EU - Europa 27
BG - Bulgaria 26
SA - Arabia Saudita 26
PK - Pakistan 25
MA - Marocco 24
CZ - Repubblica Ceca 23
IR - Iran 23
TW - Taiwan 22
VE - Venezuela 22
UZ - Uzbekistan 21
CL - Cile 19
PY - Paraguay 16
AU - Australia 14
MY - Malesia 13
AE - Emirati Arabi Uniti 12
CH - Svizzera 12
KE - Kenya 12
JO - Giordania 11
RO - Romania 11
UY - Uruguay 11
PH - Filippine 10
EG - Egitto 9
LT - Lituania 9
NZ - Nuova Zelanda 9
PE - Perù 9
DZ - Algeria 8
NO - Norvegia 8
OM - Oman 8
BO - Bolivia 7
TN - Tunisia 7
BY - Bielorussia 6
IL - Israele 6
JM - Giamaica 6
KZ - Kazakistan 6
MD - Moldavia 6
AZ - Azerbaigian 5
DO - Repubblica Dominicana 5
HU - Ungheria 5
KW - Kuwait 5
NP - Nepal 5
PT - Portogallo 5
SC - Seychelles 5
TT - Trinidad e Tobago 5
A2 - ???statistics.table.value.countryCode.A2??? 4
CR - Costa Rica 4
ET - Etiopia 4
MM - Myanmar 4
BH - Bahrain 3
GE - Georgia 3
GR - Grecia 3
HN - Honduras 3
RS - Serbia 3
TH - Thailandia 3
AL - Albania 2
AM - Armenia 2
GA - Gabon 2
HR - Croazia 2
KG - Kirghizistan 2
LB - Libano 2
LK - Sri Lanka 2
MU - Mauritius 2
NI - Nicaragua 2
PA - Panama 2
PS - Palestinian Territory 2
A1 - Anonimo 1
BA - Bosnia-Erzegovina 1
Totale 48.795
Salva come PNG Salva come JPEG
Città #
Ann Arbor 3.259
Woodbridge 2.789
Singapore 2.235
Fairfield 2.114
Hong Kong 2.035
Houston 1.903
Ashburn 1.871
Chandler 1.335
Jacksonville 1.215
Dublin 1.206
Wilmington 1.000
Seattle 880
Frankfurt am Main 817
Cambridge 769
New York 622
Dearborn 556
Princeton 534
Beijing 444
Hefei 433
Santa Clara 425
Milan 405
Ho Chi Minh City 319
Dallas 300
Nanjing 292
Los Angeles 271
Lawrence 228
Seoul 219
Hanoi 218
Altamura 204
Lachine 197
Shanghai 193
The Dalles 179
Buffalo 135
Chicago 135
Moscow 130
San Diego 129
Council Bluffs 126
Boardman 115
São Paulo 112
Guangzhou 110
Shenyang 88
Vienna 88
Toronto 77
Andover 76
Nanchang 73
Helsinki 71
Changsha 68
Ottawa 64
Hebei 63
Rome 61
Falls Church 57
London 57
Hangzhou 55
Tianjin 53
Jiaxing 50
Columbus 49
Norwalk 49
Rio de Janeiro 49
Dong Ket 47
Tokyo 47
Mountain View 45
Fremont 44
Munich 44
Philadelphia 44
Jakarta 42
Jinan 42
Brooklyn 41
Salt Lake City 40
Nuremberg 38
Zhengzhou 38
Brussels 36
Huizen 36
Boston 35
Da Nang 35
Johannesburg 34
Kunming 34
Haiphong 33
Elk Grove Village 31
Montreal 31
Pune 31
Warsaw 31
Belo Horizonte 29
Brasília 29
Lissone 29
Redmond 29
Tampa 27
Ningbo 26
Phoenix 26
San Mateo 26
Baghdad 25
Orem 25
Mexico City 24
Dhaka 23
Denver 22
Porto Alegre 22
San Francisco 22
Auburn Hills 21
Guayaquil 21
Chennai 20
Plovdiv 20
Totale 32.952
Salva come PNG Salva come JPEG
Nome #
Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma 572
Impact of multidisciplinary team approach to liver tumors: 5-Years experience 467
Impact of multidisciplinary team approach to liver tumors in a tertiary center: 5-years experience 433
JNK SIGNALING ACTIVATED BY PLATELET-DERIVED GROWTH FACTOR D (PDGF-D) STIMULATES SECRETION OF VASCULAR ENDOTHELIAL GROWTH FACTOR-C (VEGF-C) BY CANCER-ASSOCIATED FIBROBLASTS TO PROMOTE LYMPHANGIOGENESIS AND EARLY METASTATIZATION IN CHOLANGIOCARCINOMA 407
Clinical outcome indicators in chronic hepatitis B and C: A primer for value-based medicine in hepatology 393
Optimising the clinical strategy for autoimmune liver diseases: Principles of value-based medicine 333
Resveratrol impairs glioma stem cells proliferation and motility by modulating the wnt signaling pathway 323
Diagnostic Value of Quantitative Perfusion Computed Tomography Technique in the Assessment of Tumor Response to Sorafenib in Patients with Advanced Hepatocellular Carcinoma 323
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 286
Diagnostic value of dynamic contrast-enhanced CT with perfusion imaging in the quantitative assessment of tumor response to sorafenib in patients with advanced hepatocellular carcinoma: A feasibility study 281
Trattamento con Sofosbuvir e Ribavirina nei pazienti hcv-positivi listati per il trapianto di fegato: un analisi di costo-efficacia 279
Value-based outcome indicators in the management of hepatocellular carcinoma: Clinical test in a large multicenter study (VBMH study) 275
Long term outcome of acute pancreatitis in Italy: Results of a multicentre study 274
Health related quality of life in chronic liver diseases 273
Dynamic contrast enhanced perfusion CT imaging: A diagnostic biomarker tool for survival prediction of tumour response to antiangiogenetic treatment in patients with advanced HCC lesions 268
Generation and performance of value-based outcome indicators in liver disease: The multicenter V.B.M.H. study 261
Outcome indicators in liver cirrhosis: Application of value-based medicine in a large multicenter study (VBMH study) 259
Mammalian target of rapamycin regulates vascular endothelial growth factor-dependent liver cyst growth in polycystin-2-defective mice 256
P1169 : Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 253
Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 250
Pathophysiologic implications of innate immunity and autoinflammation in the biliary epithelium 249
P0811 : Sofosbuvir-based direct-acting antivirals treatment for elderly chronic hepatitis C patients: A cost-effectiveness analysis 248
HCC persistence or recurrence after bridging therapy helps predict transplant list dropout and generate a more equitable exception policy 247
Valproic Acid Inhibits Proliferation and Reduces Invasiveness in Glioma Stem Cells Through Wnt/β Catenin Signalling Activation 246
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 246
Outcome Indicators in Primary Sclerosing Cholangitis: Interim Analysis Of The Value-Based Medicine In Hepatology (VBMH) Study 243
Cholangiocyte biology as relevant to cystic liver diseases 242
Notch signaling regulates tubular morphogenesis during repair from biliary damage in mice 242
Value-based outcome indicators in liver cirrhosis: validation in a large multicenter study (VBMH study) 241
Characteristics of patients with Chronic Hepatitis C who have failed past treatment or who have never been treated: How much room left for Interferon? 241
The impact of liver disease on the health-related quality of life 241
Low-dose paclitaxel reduces S100A4 nuclear import to inhibit invasion and hematogenous metastasis of cholangiocarcinoma 239
The optimal timing of hepatitis C therapy in liver transplant-eligible patients: Cost-effectiveness analysis of new opportunities 238
Direct-acting antivirals combination for elderly patients with chronic hepatitis C: A cost-effectiveness analysis 237
Effect of Silibinin on biliary lipid composition. Experimental and clinical study 236
Pathway-based analysis of primary biliary cirrhosis genome-wide association studies 236
Measurement of clinical outcomes and quality of life indicators as a new value-based approach to liver cirrhosis management 233
Tumor reactive stroma in cholangiocarcinoma: The fuel behind cancer aggressiveness 232
Generation and Performance of Outcome Indicators in Liver Cirrhosis: The Value Based Medicine in Hepatology Study (V.B.M.H.) 231
Health Related Quality of Life in the Major Liver Conditions 231
The cystic fibrosis transmembrane conductance regulator controls biliary epithelial inflammation and permeability by regulating Src tyrosine kinase activity 228
Classical HLA-DRB1 and DPB1 alleles account for HLA associations with primary biliary cirrhosis 227
The Impact of Type of Liver Conditions on the Patients’ Health Related Quality of Life 226
A Comparison Between The Health-Related Quality Of Life Reported By The General Population And By Patients With Major Liver Diseases 225
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways 224
Epithelial expression of angiogenic growth factors modulate arterial vasculogenesis in human liver development 222
pka-dependent p-ser- 675 β-catenin phosphorylation increases cholangiocyte motility in pkhd1del4/del4 mice, a model of fibropolycystic liver diseases caused by defective fibrocystin function 220
Ursodeoxycholic acid stimulates cholangiocyte fluid secretion in mice via CFTR-dependent ATP secretion. 219
Cholangiocarcinoma in Italy: A national survey on clinical characteristics, diagnostic modalities and treatment. Results from the " Cholangiocarcinoma" committee of the Italian Association for the Study of Liver disease 217
A value-based approach to the management of patients with liver cirrhosis through the systematic measurement of clinical outcome and quality of life indicators 216
Liver-allocation policies for patients affected by HCC in Europe 216
Impatto dei farmaci anti virali ad azione diretta sulla cura dei pazienti con epatite C: un approccio di value-based medicine 216
Sofosbuvir-based all-oral treatment for elderly chronic hepatitis C patients: A cost-effectiveness analysis 215
ERK1/2-dependent vascular endothelial growth factor signaling sustains cyst growth in polycystin-2 defective mice 214
"The city of Hepar": Rituals, gastronomy, and politics at the origins of the modern names for the liver 212
Loss of CFTR affects biliary epithelium innate immunity and causes TLR4NF-κB-mediated inflammatory response in mice 212
Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants. 212
Management of treatment-naïve chronic hepatitis C genotype 1 patients: A cost-effectiveness analysis of treatment options 212
Monocyte/macrophage peribiliary recruitment by pkhd1-defective cholangiocytes induces expression of avb6 integrin on biliary cysts via tgf-β1 and tnf-α in congenital hepatic fibrosis 211
Should new antiviral treatments be considered in elderly Chronic Hepatitis C patients? 211
Models of The Impact of Major Liver Diseases on Eq-5d Visual Analogue Scale and Utility-Index: Convergences and Divergences 211
JNK SIGNALING ACTIVATED BY PLATELET-DERIVED GROWTH FACTOR D (PDGF-D) STIMULATES SECRETION OF VASCULAR ENDOTHELIAL GROWTH FACTOR-C (VEGF-C) BY CANCER-ASSOCIATED FIBROBLASTS TO PROMOTE LYMPHANGIOGENESIS AND EARLY METASTASIZATION IN CHOLANGIOCARCINOMA 210
PGI36 Relationship Between Clinical Severity and Health Related Quality of Life in Chronic Liver Diseases 210
The challenges of primary biliary cholangitis: What is new and what needs to be done 210
Foxa1 and Foxa2 regulate bile duct development in mice 209
Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching 209
Epithelial-to-Mesenchymal Transition and Cancer Invasiveness: What Can We Learn from Cholangiocarcinoma? 209
Effect of age on single- and multiple-dose pharmacokinetics of erythromycin 207
Analysis of liver repair mechanisms in Alagille syndrome and biliary atresia reveals a role for notch signaling 206
Revisiting Epithelial-to-Mesenchymal Transition in Liver Fibrosis: Clues for a Better Understanding of the "reactive" Biliary Epithelial Phenotype 206
Morphological and functional features of hepatic cyst epithelium in autosomal dominant polycystic kidney disease. 205
Intracellular alkalinization stimulates bile flow and vesicular-mediated exocytosis in IPRL 204
Value-based approach to hepatocellular carcinoma: outcome indicators tested in a large multicenter study (VBMH study) 204
Β-Catenin-Mediated Cxcl1 and Cxcl10 Secretion by Fibrocystin-Defective Cholangiocytes Regulates Peribiliary Recruitment of Fibrocytes in Congenital Hepatic Fibrosis 204
Should Sofosbuvir-Based All-Oral Treatment Be Considered In Elderly Chronic Hepatitis C Patients? 204
PGI31 Health Care Indicators to Measure Quality of Care in Patients with Liver Diseases 203
The cholangiopathies: disorders of biliary epithelia 202
Sorafenib paradoxically activates the raf/mek/erk signaling in mice with polycystic liver disease (pld) caused by conditional deletion of polycystin-2 202
Difference in health related quality of life of chronic liver diseases and general population 202
Purinergic regulation of acid/base transport in human and rat biliary epithelial cell lines. 201
Animal models of cholestasis: An update on inflammatory cholangiopathies 201
Cyclic AMP/PKA-dependent paradoxical activation of Raf/MEK/ERK signaling in polycystin-2 defective mice treated with sorafenib 200
Isolated idiopathic bile ductular hyperplasia in patients with persistently abnormal liver function tests 199
Characterization and isolation of ductular cells coexpressing neural cell adhesion molecule and Bcl-2 from primary cholangiopathies and ductal plate malformations 199
Side chain structure determines unique physiologic and therapeutic properties of norursodeoxycholic acid in Mdr2-/- mice 199
Vascular biology of the biliary epithelium 199
Cholangiocyte pathobiology 199
Pka-dependent p-ser-675-catenin phosphorylation increases cholangiocyte motility in a mouse model of fibropolycystic liver diseases 198
Intracellular pH regulation in isolated rat bile duct epithelial cells 197
Notch signaling and new therapeutic options in liver disease 196
Effect of UDCA on intracellular and biliary pH in isolated rat hepatocyte couplets and perfused livers 195
Molecular mechanisms driving cholangiocarcinoma invasiveness: an overview 195
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis 193
The Cost-Effectiveness Of Sofosbuvir And Ribavirin Treatment In Hcv-Infected Patients Listed For Liver Transplantation 193
Monocyte/macrophage peribiliary recruitment by pkhd1-defective cholangiocytes induces expression of avb6 integrin on biliary cysts via tgf-β1 and tnf-α in congenital hepatic fibrosis 193
Novel association of HLA-haplotypes with primary sclerosing cholangitis (PSC) in a southern European population 192
Liver transplant in cystic fibrosis: a poll among European centers. A study from the European Liver Transplant Registry 192
Effects of angiogenic factor overexpression by human and rodent cholangiocytes in polycystic liver diseases 192
Altered store operated calcium entry increases cAMP production and ERK1/2 phosphorylation in Polycystin-2 defective cholangiocytes 192
Subcutaneous insulin infusion (CSII) in italy: The third national survey [La terapia insulinica sottocutanea continua (CSII) in Italia. Terza indagine nazionale] 192
Totale 23.654
Salva come PNG Salva come JPEG
Categoria #
all - tutte 171.892
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 171.892
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.351 0 0 0 0 0 269 378 313 380 434 274 303
2021/20222.877 130 293 499 219 101 210 133 197 143 199 244 509
2022/20235.338 594 1.602 470 404 435 810 72 278 369 31 178 95
2023/20243.783 151 142 112 179 505 1.038 764 139 333 33 24 363
2024/20258.323 551 1.073 423 324 775 275 522 405 757 1.178 652 1.388
2025/20269.139 2.210 1.393 1.359 1.726 2.090 361 0 0 0 0 0 0
Totale 49.820